GOVERNANCE

Governance

The Jersey Biopharma Council operates under a governance structure designed to support the responsible coordination of the sector and constructive engagement with government and regulatory stakeholders.

The Council is being established as a not-for-profit company limited by guarantee, to be governed by its members in accordance with its Memorandum and Articles of Association.

The Council brings together member organisations working across Jersey’s regulated biopharmaceutical sector and provides a forum for collaboration, policy engagement and the promotion of high operational and regulatory standards.

STRUCTURE

Council Structure

The Council brings together representatives from member organisations operating across Jersey’s regulated biopharmaceutical sector.

Through this structure, the Council provides a forum for collaboration between industry participants and facilitates constructive engagement with government, regulators and other stakeholders.

The Council’s activities focus on supporting operational stability, maintaining high sector standards and contributing to discussions relating to the responsible development of the industry.

MEMBER REPRESENTATION

Role of Member Organisations

Member organisations form the core of the Council’s governance and activities.

Companies participating in the Council contribute their operational experience, regulatory expertise and sector knowledge to help inform discussions and support the responsible development of the industry.

The Council operates on a member-led basis, with members collectively guiding its priorities and strategic direction.

Through collaboration within the Council, members aim to promote high standards, share expertise, and support the long-term credibility of Jersey’s regulated biopharmaceutical sector.

GOVERNANCE PRINCIPLES

Governance Principles

The Jersey Biopharma Council operates according to several core principles that guide its activities and engagement with stakeholders.

These include:

• Supporting responsible and disciplined sector development
• Promoting high operational and regulatory standards
• Maintaining constructive engagement with government and regulators
• Supporting policies that protect Jersey’s reputation as a trusted jurisdiction
• Encouraging long-term economic value for the Island

The Council seeks to ensure that the development of the sector remains aligned with Jersey’s wider economic and institutional interests.

RESPONSIBLE DEVELOPMENT

Commitment to Responsible Industry Development

The regulated biopharmaceutical sector in Jersey remains at an early stage of development. The Council exists in part to support the careful and responsible evolution of the industry.

By encouraging collaboration between industry participants and maintaining open dialogue with regulators and policymakers, the Council aims to help ensure that growth occurs in a stable, well-governed and credible manner.

This approach reflects the importance of protecting the Island’s long-standing reputation for strong regulation, institutional stability and high standards.